Deep Track Capital, LP Spring Works Therapeutics, Inc. Transaction History
Deep Track Capital, LP
- $2.71 Billion
- Q3 2024
A detailed history of Deep Track Capital, LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 3,843,900 shares of SWTX stock, worth $147 Million. This represents 4.54% of its overall portfolio holdings.
Number of Shares
3,843,900
Previous 3,700,000
3.89%
Holding current value
$147 Million
Previous $139 Million
11.64%
% of portfolio
4.54%
Previous 4.57%
Shares
8 transactions
Others Institutions Holding SWTX
# of Institutions
237Shares Held
68.9MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$256 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$215 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$134 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$131 Million5.82% of portfolio
-
State Street Corp Boston, MA3.09MShares$118 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.38B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...